New Horizon Biotech
Bethlehem
About New Horizon Biotech
- Next-Gen Fermentors For Next-Gen Business Needs - New Horizon Biotechnologies (NHB) is currently concluding testing of its patented Single Use Horizontal Fermentor system (SUHF™). These studies demonstrate the effectiveness of the system for single-use microbial fermentation and compares and contrasts it with legacy designs currently in use. Microbial fermentation is the basis for the production of a wide range of high value biopharmaceutical products, including antibiotics, vaccines, and therapeutic proteins. NHB intends to deliver production and operational cost savings and efficiencies with its new SUHF™ system that will fundamentally improve the global competitive edge of its users.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $256.0K
- Funding stage: Seed
- Last round: Grant (Mar 2021)
- Website: newhorizonbiotech.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/new-horizon-biotech-172739 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.